This patent covers the composition of matter for a small molecule inhibitor of p38 MAP kinase, as well as the use of these compounds for stimulation/acceleration of bone healing. Presumably since p38 is involved in inflammatory signaling, the inhibition of this pathway allows for regenerative activities to prevail, thus allowing healing unimpeded by inflammation. Indeed one of the claims does cover the inhibition of p38 MAP kinase as a method of decreasing activity of osteoclasts.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.